Regenerative medicine experts

What our regenerative medicine experts do

Triple Helix Science repairs damaged tissue by pairing stem cell biology with targeted gene therapies aimed at the cellular mechanism behind the structural loss, not at the symptom it produces. Specialists identify that mechanism first, then design a protocol around it, then write it for delivery at national scale through a sovereign health system rather than for one clinic at a time. The resulting protocols are proprietary and IP-protected. They are designed to sit alongside the firm's muscle biology programme, which covers neuromuscular health and tissue repair, and its metabolic and neurodegeneration research.

How they work

Regenerative medicine experts are judged on whether restored function holds, which is a harder standard than whether tissue repairs at all. Triple Helix Science treats a repair as provisional while the systems around it are still degrading, so regenerative design is tested against mitochondrial efficiency, autophagy, genomic stability and neuromuscular condition rather than against the target tissue alone. Protocol development is done in house and kept under the firm's own IP, which means the regenerative work and the metabolic and muscle programmes it depends on come from one research group rather than from licensed parts assembled afterwards.

When to bring them in

Regenerative medicine experts become relevant when structural tissue damage is being managed rather than reversed, and when the body responsible for it is a health system rather than a single patient. Triple Helix Science works with governments, research universities, sovereign wealth funds and enterprise pharmaceutical organisations, and does not operate as a direct-to-consumer provider, so engagements are institutional from the outset. The usual trigger is an ageing population and a chronic disease burden that reactive care cannot hold, where the measure that matters is healthspan rather than lifespan.